These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 9647783
21. The function of the multidrug resistance proteins (MRP and cMRP) in drug conjugate transport and hepatobiliary excretion. Keppler D, Leier I, Jedlitschky G, Mayer R, Büchler M. Adv Enzyme Regul; 1996; 36():17-29. PubMed ID: 8869738 [Abstract] [Full Text] [Related]
25. Multidrug resistance-associated protein (MRP) mediated transport of daunomycin and leukotriene C4 (LTC4) in isolated plasma membrane vesicles. Ding GY, Shen T, Center MS. Anticancer Res; 1999 Jun; 19(4B):3243-8. PubMed ID: 10652618 [Abstract] [Full Text] [Related]
26. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P. Marbeuf-Gueye C, Salerno M, Quidu P, Garnier-Suillerot A. Eur J Pharmacol; 2000 Mar 17; 391(3):207-16. PubMed ID: 10729360 [Abstract] [Full Text] [Related]
27. Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. Ishikawa T, Ali-Osman F. J Biol Chem; 1993 Sep 25; 268(27):20116-25. PubMed ID: 8376370 [Abstract] [Full Text] [Related]
28. Differences in substrate specificity among glutathione conjugates (GS-X) pump family members: comparison between multidrug resistance-associated protein and a novel transporter expressed on a cisplatin-resistant cell line (KCP-4). Ueda K, Suzuki H, Akiyama S, Sugiyama Y. Jpn J Cancer Res; 1999 Apr 25; 90(4):439-47. PubMed ID: 10363583 [Abstract] [Full Text] [Related]
29. Transport of leukotriene C4 and structurally related conjugates. Jedlitschky G, Keppler D. Vitam Horm; 2002 Apr 25; 64():153-84. PubMed ID: 11898391 [Abstract] [Full Text] [Related]
30. Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3). Grant CE, Gao M, DeGorter MK, Cole SP, Deeley RG. Drug Metab Dispos; 2008 Dec 25; 36(12):2571-81. PubMed ID: 18775981 [Abstract] [Full Text] [Related]
31. Enhancement of glucuronosyl etoposide transport by glutathione in multidrug resistance-associated protein-overexpressing cells. Sakamoto H, Hara H, Hirano K, Adachi T. Cancer Lett; 1999 Jan 08; 135(1):113-9. PubMed ID: 10077229 [Abstract] [Full Text] [Related]
32. Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin. Wortelboer HM, Usta M, van der Velde AE, Boersma MG, Spenkelink B, van Zanden JJ, Rietjens IM, van Bladeren PJ, Cnubben NH. Chem Res Toxicol; 2003 Dec 08; 16(12):1642-51. PubMed ID: 14680379 [Abstract] [Full Text] [Related]
33. Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells. Stride BD, Grant CE, Loe DW, Hipfner DR, Cole SP, Deeley RG. Mol Pharmacol; 1997 Sep 08; 52(3):344-53. PubMed ID: 9281595 [Abstract] [Full Text] [Related]
34. Role of multidrug resistance protein (MRP) in glutathione S-conjugate transport in mammalian cells. Müller M, de Vries EG, Jansen PL. J Hepatol; 1996 Sep 08; 24 Suppl 1():100-8. PubMed ID: 8926361 [Abstract] [Full Text] [Related]
35. Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function. Chen ZS, Aoki S, Komatsu M, Ueda K, Sumizawa T, Furukawa T, Okumura H, Ren XQ, Belinsky MG, Lee K, Kruh GD, Kobayashi M, Akiyama S. Int J Cancer; 2001 Jul 01; 93(1):107-13. PubMed ID: 11391629 [Abstract] [Full Text] [Related]
36. Identification of the multidrug-resistance protein (MRP) as the glutathione-S-conjugate export pump of erythrocytes. Pulaski L, Jedlitschky G, Leier I, Buchholz U, Keppler D. Eur J Biochem; 1996 Oct 15; 241(2):644-8. PubMed ID: 8917467 [Abstract] [Full Text] [Related]
37. RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance. Sharma R, Singhal SS, Wickramarachchi D, Awasthi YC, Awasthi S. Int J Cancer; 2004 Dec 20; 112(6):934-42. PubMed ID: 15386349 [Abstract] [Full Text] [Related]
38. Gamma-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistance. Kurokawa H, Ishida T, Nishio K, Arioka H, Sata M, Fukumoto H, Miura M, Saijo N. Biochem Biophys Res Commun; 1995 Nov 02; 216(1):258-64. PubMed ID: 7488097 [Abstract] [Full Text] [Related]
39. Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a tri-glutathione conjugate is required. Leslie EM, Haimeur A, Waalkes MP. J Biol Chem; 2004 Jul 30; 279(31):32700-8. PubMed ID: 15161912 [Abstract] [Full Text] [Related]
40. Induction of MRP/GS-X pump and cellular resistance to anticancer prostaglandins. Akimaru K, Kuo MT, Furuta K, Suzuki M, Noyori R, Ishikawa T. Cytotechnology; 1996 Jul 30; 19(3):221-7. PubMed ID: 8862010 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]